135 related articles for article (PubMed ID: 35343088)
61. Roadside detection of impairment under the influence of ketamine--evaluation of ketamine impairment symptoms with reference to its concentration in oral fluid and urine.
Cheng WC; Ng KM; Chan KK; Mok VK; Cheung BK
Forensic Sci Int; 2007 Jul; 170(1):51-8. PubMed ID: 17046188
[TBL] [Abstract][Full Text] [Related]
62. Evaluation of Δ(9) -tetrahydrocannabinol detection using DrugWipe5S(®) screening and oral fluid quantification after Quantisal™ collection for roadside drug detection via a controlled study with chronic cannabis users.
Wille SM; Di Fazio V; Toennes SW; van Wel JH; Ramaekers JG; Samyn N
Drug Test Anal; 2015 Mar; 7(3):178-86. PubMed ID: 24753449
[TBL] [Abstract][Full Text] [Related]
63. A field test of substance use screening devices as part of routine drunk-driving spot detection operating procedures in South Africa.
Matzopoulos R; Lasarow A; Bowman B
Accid Anal Prev; 2013 Oct; 59():118-24. PubMed ID: 23770390
[TBL] [Abstract][Full Text] [Related]
64. A comparison between on-site immunoassay drug-testing devices and laboratory results.
Grönholm M; Lillsunde P
Forensic Sci Int; 2001 Sep; 121(1-2):37-46. PubMed ID: 11516886
[TBL] [Abstract][Full Text] [Related]
65. Suspicion of driving under the influence of alcohol or drugs: Cross sectional analysis of drug prevalence in the context of the Swiss legislation.
Maurer J; Vergalito E; Prior AF; Donzé N; Thomas A; Augsburger M
Forensic Sci Int; 2021 Dec; 329():111081. PubMed ID: 34741989
[TBL] [Abstract][Full Text] [Related]
66. A retrospective study of traffic offenses associated with driving under the influence of drugs in China.
Li F
Traffic Inj Prev; 2024; 25(2):103-109. PubMed ID: 38054845
[TBL] [Abstract][Full Text] [Related]
67. Oral fluid testing for driving under the influence of drugs: history, recent progress and remaining challenges.
Verstraete AG
Forensic Sci Int; 2005 Jun; 150(2-3):143-50. PubMed ID: 15944054
[TBL] [Abstract][Full Text] [Related]
68. Drugs and driving.
Walsh JM; de Gier JJ; Christopherson AS; Verstraete AG
Traffic Inj Prev; 2004 Sep; 5(3):241-53. PubMed ID: 15276925
[TBL] [Abstract][Full Text] [Related]
69. Prevalence of drugs in oral fluid from truck drivers in Brazilian highways.
Bombana HS; Gjerde H; Dos Santos MF; Jamt REG; Yonamine M; Rohlfs WJC; Muñoz DR; Leyton V
Forensic Sci Int; 2017 Apr; 273():140-143. PubMed ID: 28273545
[TBL] [Abstract][Full Text] [Related]
70. Field Detection of Drugs of Abuse in Oral Fluid Using the Alere™ DDS®2 Mobile Test System with Confirmation by Liquid Chromatography Tandem Mass Spectrometry (LC-MS/MS).
Krotulski AJ; Mohr ALA; Friscia M; Logan BK
J Anal Toxicol; 2018 Apr; 42(3):170-176. PubMed ID: 29301050
[TBL] [Abstract][Full Text] [Related]
71. Roadside Drug Testing Approaches.
Alhefeiti MA; Barker J; Shah I
Molecules; 2021 May; 26(11):. PubMed ID: 34072538
[TBL] [Abstract][Full Text] [Related]
72. Analytical evaluation of four on-site oral fluid drug testing devices.
Vanstechelman S; Isalberti C; Van der Linden T; Pil K; Legrand SA; Verstraete AG
J Anal Toxicol; 2012 Mar; 36(2):136-40. PubMed ID: 22337784
[TBL] [Abstract][Full Text] [Related]
73. UHPLC-ESI-MS/MS method for direct analysis of drugs of abuse in oral fluid for DUID assessment.
Strano-Rossi S; Anzillotti L; Castrignanò E; Felli M; Serpelloni G; Mollica R; Chiarotti M
Anal Bioanal Chem; 2011 Aug; 401(2):609-24. PubMed ID: 21674163
[TBL] [Abstract][Full Text] [Related]
74. Driving under the influence of cannabis: a 10-year study of age and gender differences in the concentrations of tetrahydrocannabinol in blood.
Jones AW; Holmgren A; Kugelberg FC
Addiction; 2008 Mar; 103(3):452-61. PubMed ID: 18190663
[TBL] [Abstract][Full Text] [Related]
75. Analytical reliability of four oral fluid point-of-collection testing devices for drug detection in drivers.
Scherer JN; Schuch JB; Rabelo-da-Ponte FD; Silvestrin R; Ornell R; Sousa T; Limberger RP; Pechansky F
Forensic Sci Int; 2020 Oct; 315():110434. PubMed ID: 32758788
[TBL] [Abstract][Full Text] [Related]
76. The Victorian legislative framework for the random testing drivers at the roadside for the presence of illicit drugs: an evaluation of the characteristics of drivers detected from 2004 to 2006.
Boorman M; Owens K
Traffic Inj Prev; 2009 Mar; 10(1):16-22. PubMed ID: 19214873
[TBL] [Abstract][Full Text] [Related]
77. Detection of Δ
Arkell TR; Kevin RC; Stuart J; Lintzeris N; Haber PS; Ramaekers JG; McGregor IS
Drug Test Anal; 2019 Oct; 11(10):1486-1497. PubMed ID: 31442003
[TBL] [Abstract][Full Text] [Related]
78. Driving under the influence of psychoactive substances - A historical review.
Jones AW; Mørland JG; Liu RH
Forensic Sci Rev; 2019 Jul; 31(2):103-140. PubMed ID: 31270058
[TBL] [Abstract][Full Text] [Related]
79. Orally administered cannabidiol does not produce false-positive tests for Δ
McCartney D; Kevin RC; Suraev AS; Irwin C; Grunstein RR; Hoyos CM; McGregor IS
Drug Test Anal; 2022 Jan; 14(1):137-143. PubMed ID: 34412166
[TBL] [Abstract][Full Text] [Related]
80. Prevalence of psychoactive substances, alcohol and illicit drugs, in Spanish drivers: A roadside study in 2015.
Domingo-Salvany A; Herrero MJ; Fernandez B; Perez J; Del Real P; González-Luque JC; de la Torre R
Forensic Sci Int; 2017 Sep; 278():253-259. PubMed ID: 28778032
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
